||EPA's Endocrine Disruptor Screening Program Should Establish Management Controls to Ensure More Timely Results. Evaluation Report.
R. Beusse ;
H. C. Garduno ;
K. Good ;
R. McGhee-Lenart ;
||Environmental Protection Agency, Washington, DC. Office of the Inspector General.
Toxic substances ;
Endocrine effects ;
Management controls ;
Androgenic effects ;
Thyroid effects ;
Human health ;
Environmental effects ;
Endocrine diseases ;
Monetary benefits ;
Endocrine-disrupting chemicals ;
Environmental Protection Agency (EPA) ;
Endocrine Disruptor Screening Program (EDSP)
||Some EPA libraries have a fiche copy filed under the call number shown.
||We sought to determine whether the U.S. Environmental Protection Agency (EPA) has planned and conducted the requisite research and testing to evaluate and regulate endocrine-disrupting chemicals. We focused on EPA's Endocrine Disruptor Screening Program (EDSP) because it is the program that focuses on screening and testing chemicals with endocrine-disrupting effects. In 1996, Congress passed the Food Quality Protection Act (FQPA), which gave EPA the authority to screen and test substances that may have an effect in humans that is similar to that of a naturally occurring estrogen, or such other endocrine effects as the EPA Administrator may designate. In 1998, EPA established the EDSP, which uses a two-tiered screening and testing approach to assess endocrine effects. EDSP was expanded to include androgenic and thyroid effects.
||Order this product from NTIS by: phone at 1-800-553-NTIS (U.S. customers); (703)605-6000 (other countries); fax at (703)605-6900; and email at firstname.lastname@example.org. NTIS is located at 5301 Shawnee Road, Alexandria, VA, 22312, USA.
|PUB Date Free Form
||3 May 2011
||68G; 57H; 57U; 57Y